Literature DB >> 22981536

Cell volume regulation modulates NLRP3 inflammasome activation.

Vincent Compan1, Alberto Baroja-Mazo, Gloria López-Castejón, Ana I Gomez, Carlos M Martínez, Diego Angosto, María T Montero, Antonio S Herranz, Eulalia Bazán, Diana Reimers, Victoriano Mulero, Pablo Pelegrín.   

Abstract

Cell volume regulation is a primitive response to alterations in environmental osmolarity. The NLRP3 inflammasome is a multiprotein complex that senses pathogen- and danger-associated signals. Here, we report that, from fish to mammals, the basic mechanisms of cell swelling and regulatory volume decrease (RVD) are sensed via the NLRP3 inflammasome. We found that a decrease in extracellular osmolarity induced a K(+)-dependent conformational change of the preassembled NLRP3-inactive inflammasome during cell swelling, followed by activation of the NLRP3 inflammasome and caspase-1, which was controlled by transient receptor potential channels during RVD. Both mechanisms were necessary for interleukin-1β processing. Increased extracellular osmolarity prevented caspase-1 activation by different known NLRP3 activators. Collectively, our data identify cell volume regulation as a basic conserved homeostatic mechanism associated with the formation of the NLRP3 inflammasome and reveal a mechanism for NLRP3 inflammasome activation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Mesh:

Substances:

Year:  2012        PMID: 22981536     DOI: 10.1016/j.immuni.2012.06.013

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  159 in total

1.  In vivo imaging of inflammasome activation reveals a subcapsular macrophage burst response that mobilizes innate and adaptive immunity.

Authors:  Pervinder Sagoo; Zacarias Garcia; Beatrice Breart; Fabrice Lemaître; David Michonneau; Matthew L Albert; Yves Levy; Philippe Bousso
Journal:  Nat Med       Date:  2015-12-21       Impact factor: 53.440

Review 2.  Tissue biology perspective on macrophages.

Authors:  Yasutaka Okabe; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2016-01       Impact factor: 25.606

Review 3.  TRPing on the pore phenomenon: what do we know about transient receptor potential ion channel-related pore dilation up to now?

Authors:  L G B Ferreira; R X Faria
Journal:  J Bioenerg Biomembr       Date:  2016-01-04       Impact factor: 2.945

Review 4.  The emerging role of the inflammasome in kidney diseases.

Authors:  Anthony Chang; Kichul Ko; Marcus R Clark
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-05       Impact factor: 2.894

Review 5.  Regulation of inflammasome activation.

Authors:  Si Ming Man; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

Review 6.  Initiation and perpetuation of NLRP3 inflammasome activation and assembly.

Authors:  Eric I Elliott; Fayyaz S Sutterwala
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

Review 7.  Pyroptotic cell death defends against intracellular pathogens.

Authors:  Ine Jorgensen; Edward A Miao
Journal:  Immunol Rev       Date:  2015-05       Impact factor: 12.988

8.  Topical Application of the Antimicrobial Agent Triclosan Induces NLRP3 Inflammasome Activation and Mitochondrial Dysfunction.

Authors:  Lisa M Weatherly; Hillary L Shane; Sherri A Friend; Ewa Lukomska; Rachel Baur; Stacey E Anderson
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

Review 9.  Inflammasomes and intestinal inflammation.

Authors:  N Zmora; M Levy; M Pevsner-Fishcer; E Elinav
Journal:  Mucosal Immunol       Date:  2017-04-12       Impact factor: 7.313

10.  Triclosan disrupts immune cell function by depressing Ca2+ influx following acidification of the cytoplasm.

Authors:  Suraj Sangroula; Alan Y Baez Vasquez; Prakash Raut; Bright Obeng; Juyoung K Shim; Grace D Bagley; Bailey E West; John E Burnell; Marissa S Kinney; Christian M Potts; Sasha R Weller; Joshua B Kelley; Samuel T Hess; Julie A Gosse
Journal:  Toxicol Appl Pharmacol       Date:  2020-08-21       Impact factor: 4.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.